Results 211 to 220 of about 2,875,336 (355)

The NAVETA obesity consensus tool: a multidimensional framework for clinical and patient-reported outcome assessment. [PDF]

Front Endocrinol (Lausanne)
Mercadal-Orfila G, Lluch-Taltavull J, Cuatrecasas G, García JM, Maestre-Fullana MA, Herrera-Pérez S.   +5 more
europepmc   +1 more source

Quantifying the burden of systemic sclerosis in Australia: From data linkage to patient reported outcomes

, 2018
Kathleen Morrisroe
openalex   +1 more source

Contralateral Submandibular Gland Sparing in Head and Neck Squamous Cell Carcinoma Is Safe and Improves Patient-Reported Outcomes (PROs) [PDF]

, 2015
Yan‐Ping Mao, S. Samuels, Eli Sapir, Avraham Eisbruch   +3 more
openalex   +1 more source

Plasma extrachromosomal circular DNA as a biomarker in EGFR‐targeted therapy of non‐small cell lung cancer

Molecular Oncology, EarlyView.
Detection of extrachromosomal circular DNA (eccDNA) in plasma samples from EGFR‐mutated non‐small cell lung cancer patients. Plasma was collected before and during treatment with the EGFR‐tyrosine kinase inhibitor osimertinib. Plasma eccDNA was detected in all cancer samples, and the presence of the EGFR gene on eccDNA serves as a potential biomarker ...
Simone Stensgaard, Sarmad Mehmood, Eva Boysen Fynboe Ebert, Peter Meldgaard, Anindya Dutta, Boe S. Sorensen   +5 more
wiley   +1 more source

Systematic review of patient-reported outcome measures for opioid use disorder recovery. [PDF]

Addiction
Pytell JD, Pales D, Simon C, Beaudoin J, Osman AMY, Svoboda E, Christine PJ, Matlock D, Schwartz R, Binswanger IA.   +9 more
europepmc   +1 more source

Psychometric analyses of patient-reported outcome instruments for autosomal dominant polycystic kidney disease [PDF]

, 2013
Jason C. Cole, Rebecca Cheng, Dorothee Oberdhan, H. B. Krasa, Ron D. Hays   +4 more
openalex   +1 more source

Screening for lung cancer: A systematic review of overdiagnosis and its implications

Molecular Oncology, EarlyView.
Low‐dose computed tomography (CT) screening for lung cancer may increase overdiagnosis compared to no screening, though the risk is likely low versus chest X‐ray. Our review of 8 trials (84 660 participants) shows added costs. Further research with strict adherence to modern nodule management strategies may help determine the extent to which ...
Fiorella Karina Fernández‐Sáenz, Laura de la Torre‐Perez, David R Baldwin, Carlijn van der Aalst, Mangesh Thorat, David Ritchie, Andre L Carvalho, Carolina Espina, Ivan Solà, Carlos Canelo‐Aybar, Moira Magdalena Pissinis, Pablo Alonso‐Coello, Ana Carolina Pereira Nunes Pinto   +12 more
wiley   +1 more source

Readability Analysis of Commonly Cited Patient-Reported Outcome Measures in the Orthopaedic Joint Literature. [PDF]

Arthroplast Today
Uppal H, Garcia D, Rezzadeh K, Sahai N, McGinniss A, Emami A, Rifai A.   +6 more
europepmc   +1 more source

Victoria: patient outcomes in palliative care: January - June 2014: report 17

, 2014
Alanna M Holloway, Samuel F Allingham, Sabina P Clapham, Jane Connolly, Karen Quinsey, Linda M Foskett   +5 more
openalex   +1 more source

Glycosylated LGALS3BP is highly secreted by bladder cancer cells and represents a novel urinary disease biomarker

Molecular Oncology, EarlyView.
Urinary LGALS3BP is elevated in bladder cancer patients compared to healthy controls as detected by the 1959 antibody–based ELISA. The antibody shows enhanced reactivity to the high‐mannose glycosylated variant secreted by cancer cells treated with kifunensine (KIF).
Asia Pece, Giulio Lovato, Ilaria Cela, Arianna Mercatelli, Benedetta Ferro, Jussi Nikkola, Sara Pagotto, Tommaso Grottola, Vincenzo De Laurenzi, Rossella Cicchetti, Antonio Marchetti, Luigi Schips, Rossano Lattanzio, Stefano Iacobelli, Emily Capone, Peter Black, Mads Daugaard, Michele Marchioni, Gianluca Sala   +18 more
wiley   +1 more source